Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
Chronic Disease Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial December 24, 2025
Chronic Disease Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial December 22, 2025
Neurology Selective serotonin reuptake inhibitors do not affect cognitive function through breastmilk November 24, 2025
Chronic Disease Exposure to components of fine particulate matter is associated with risk of autism spectrum disorder October 27, 2025
